Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alastair M Thompson

Showing results (71-80 of 195) with videos related to

Pageof 20
Sort By:
BMC Research Notes|March 23, 2011
FGFR2 protein expression in breast cancer: nuclear localisation and correlation with patient genotypeAmy J Martin, Andrew Grant, Alison M Ashfield, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
Single cell genome and epigenome co-profiling reveals hardwiring and plasticity in breast cancerKaile Wang, Yun Yan, Heba Elgamal, et al.
Cell Stress & Chaperones|March 2, 2022
Cluster analyses of the TCGA and a TMA dataset using the coexpression of HSP27 and CRYAB improves alignment with clinical-pathological parameters of breast cancer and suggests different epichaperome influences for each sHSPPhilip R Quinlan, Grazziela Figeuredo, Nigel Mongan, et al.
The Journal of Pathology|April 2, 2014
Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor statusPavla Bouchalova, Rudolf Nenutil, Petr Muller, et al.
BMC Cancer|October 3, 2008
MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphismFiona E M Paulin, Mary O'Neill, Gillian McGregor, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2026
Elucidating cooperative genetic events in DCIS progression in mutant <i>p53</i>-driven breast cancerRhiannon L Morrissey, Joy M McDaniel, Gilda P Chau, et al.
Cancer|February 22, 2022
"Is it cancer or not?" A qualitative exploration of survivor concerns surrounding the diagnosis and treatment of ductal carcinoma in situShoshana M Rosenberg, Jennifer M Gierisch, Anna C Revette, et al.
American Journal of Epidemiology|December 19, 2016
Cytochrome P-450 2D6 (CYP2D6) Genotype and Breast Cancer Recurrence in Tamoxifen-Treated Patients: Evaluating the Importance of Loss of HeterozygosityThomas P Ahern, Daniel L Hertz, Per Damkier, et al.
Cancers|October 27, 2018
Druggable <i>Nucleolin</i> Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological ProcessesFlora Nguyen Van Long, Audrey Lardy-Cleaud, Susan Bray, et al.
JNCI Cancer Spectrum|May 1, 2026
Exploration of BMI and circulating metabolic factors as predictors of metformin benefit in CCTG MA.32Pamela J Goodwin, Marguerite Ennis, Bingshu E Chen, et al.
Pageof 20

Showing results (71-80 of 195) with videos related to

Sort By:
Pageof 20
BMC Research Notes|March 23, 2011
FGFR2 protein expression in breast cancer: nuclear localisation and correlation with patient genotypeAmy J Martin, Andrew Grant, Alison M Ashfield, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
Single cell genome and epigenome co-profiling reveals hardwiring and plasticity in breast cancerKaile Wang, Yun Yan, Heba Elgamal, et al.
Cell Stress & Chaperones|March 2, 2022
Cluster analyses of the TCGA and a TMA dataset using the coexpression of HSP27 and CRYAB improves alignment with clinical-pathological parameters of breast cancer and suggests different epichaperome influences for each sHSPPhilip R Quinlan, Grazziela Figeuredo, Nigel Mongan, et al.
The Journal of Pathology|April 2, 2014
Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor statusPavla Bouchalova, Rudolf Nenutil, Petr Muller, et al.
BMC Cancer|October 3, 2008
MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphismFiona E M Paulin, Mary O'Neill, Gillian McGregor, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2026
Elucidating cooperative genetic events in DCIS progression in mutant <i>p53</i>-driven breast cancerRhiannon L Morrissey, Joy M McDaniel, Gilda P Chau, et al.
Cancer|February 22, 2022
"Is it cancer or not?" A qualitative exploration of survivor concerns surrounding the diagnosis and treatment of ductal carcinoma in situShoshana M Rosenberg, Jennifer M Gierisch, Anna C Revette, et al.
American Journal of Epidemiology|December 19, 2016
Cytochrome P-450 2D6 (CYP2D6) Genotype and Breast Cancer Recurrence in Tamoxifen-Treated Patients: Evaluating the Importance of Loss of HeterozygosityThomas P Ahern, Daniel L Hertz, Per Damkier, et al.
Cancers|October 27, 2018
Druggable <i>Nucleolin</i> Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological ProcessesFlora Nguyen Van Long, Audrey Lardy-Cleaud, Susan Bray, et al.
JNCI Cancer Spectrum|May 1, 2026
Exploration of BMI and circulating metabolic factors as predictors of metformin benefit in CCTG MA.32Pamela J Goodwin, Marguerite Ennis, Bingshu E Chen, et al.
Pageof 20